BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2173470)

  • 1. Specific transfer factor with activity against Epstein-Barr virus reduces late relapse in endemic Burkitt's lymphoma.
    Neequaye J; Viza D; Pizza G; Levine PH; De Vinci C; Ablashi DV; Biggar RJ; Nkrumah FK
    Anticancer Res; 1990; 10(5A):1183-7. PubMed ID: 2173470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer factor in prevention of Burkitt's lymphoma relapses.
    Nkrumah FK; Pizza G; Neequaye J; Viza D; De Vinci C; Levine PH
    J Exp Pathol; 1987; 3(4):463-9. PubMed ID: 2842479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very late relapses in patients with Burkitt's lymphoma: clinical and serologic studies.
    Biggar RJ; Nkrumah FK; Henle W; Levine PH
    J Natl Cancer Inst; 1981 Mar; 66(3):439-44. PubMed ID: 6259398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and demographic characteristics of Epstein-Barr virus-associated childhood Burkitt's lymphoma in Southeastern Brazil: epidemiological insights from an intermediate risk region.
    Hassan R; Klumb CE; Felisbino FE; Guiretti DM; White LR; Stefanoff CG; Barros MH; Seuánez HN; Zalcberg IR
    Haematologica; 2008 May; 93(5):780-3. PubMed ID: 18367488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burkitt's lymphoma in Europe.
    Philip T
    IARC Sci Publ; 1985; (60):107-18. PubMed ID: 2998984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Burkitt's lymphoma-Epstein-Barr virus association in western Algeria. Clinical, cytological and serological aspects apropos of 34 pediatric cases].
    Meziane F; Aguercif M; Chevallier A; Lavoue MF; Boukli H; Mehadji M; Boughermouh M
    Pediatrie; 1985 Mar; 40(2):87-98. PubMed ID: 3001633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue chemotherapy for patients with resistant or relapsed endemic Burkitt's lymphoma.
    Hesseling PB; Molyneux E; Kamiza S; Broadhead R
    Trans R Soc Trop Med Hyg; 2008 Jun; 102(6):602-7. PubMed ID: 18417177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family environment is associated with endemic Burkitt lymphoma: a population-based case-control study.
    Rainey JJ; Rochford R; Sumba PO; Kowuor D; Wilson ML; Moormann AM
    Am J Trop Med Hyg; 2008 Feb; 78(2):338-43. PubMed ID: 18256442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro studies of immunotherapy of nasopharyngeal carcinoma with transfer factor.
    Goldenberg GJ; Brandes LJ
    Cancer Res; 1976 Feb; 36(2 pt 2):720-3. PubMed ID: 1253157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
    Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
    Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-associated Burkitt's lymphoma in India.
    Venkitaraman AR; John TJ; Rangad F; Singh AD; Date A; Lenoir G
    Trop Geogr Med; 1983 Sep; 35(3):273-7. PubMed ID: 6316592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Maxillofacial location of Burkitt's lymphoma in children treated at the University Hospital Center in Bamako, Mali: a 24-case series].
    Togo B; Keita M; Medefo D; Traore F; Sidibe T
    Med Trop (Mars); 2008 Dec; 68(6):600-2. PubMed ID: 19639827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etiology of endemic Burkitt's lymphoma.
    Olweny CL
    IARC Sci Publ; 1984; (63):647-53. PubMed ID: 6100285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burkitt's lymphoma in Brazil: strong association with Epstein-Barr virus.
    Bacchi MM; Bacchi CE; Alvarenga M; Miranda R; Chen YY; Weiss LM
    Mod Pathol; 1996 Jan; 9(1):63-7. PubMed ID: 8821959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus and Burkitt's lymphoma worldwide: the causal relationship revisited.
    de-Thé G
    IARC Sci Publ; 1985; (60):165-76. PubMed ID: 2998987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epstein-Barr virus and Burkitt's lymphoma].
    Joab I
    Med Trop (Mars); 1999; 59(4 Pt 2):499-502. PubMed ID: 10901854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of residual abdominal masses in children with abdominal Burkitt's lymphoma.
    Karmazyn B; Ash S; Goshen Y; Yaniv I; Horev G; Kornreich L
    Pediatr Radiol; 2001 Nov; 31(11):801-5. PubMed ID: 11692238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is there a functional equivalence between abnormalities of the long arm of chromosome 1 and the presence of Epstein-Barr virus in continuous lines of Burkitt's lymphoma?].
    Berger R; Bernheim A
    C R Acad Sci III; 1984; 298(6):143-5. PubMed ID: 6324967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with MYC rearrangement.
    Barth TF; Müller S; Pawlita M; Siebert R; Rother JU; Mechtersheimer G; Kitinya J; Bentz M; Möller P
    J Pathol; 2004 Aug; 203(4):940-5. PubMed ID: 15258997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.